Orthopedic Devices Market Forecasts to 2030 - Global Analysis By Product Type, Material Type, Distribution Channel, End User and By Geography

According to Stratistics MRC, the Global Orthopedic Devices Market is accounted for $63.7 billion in 2024 and is expected to reach $87.8 billion by 2030, growing at a CAGR of 5.5% during the forecast period. Orthopedic devices are used to identify, treat, and prevent diseases that impact the musculoskeletal system, which is made up of the bones, joints, ligaments, tendons, and muscles. These tools are vital for treating a wide range of orthopedic ailments, including congenital malformations, arthritis, fractures, and sports injuries. Simple braces and splints to intricate surgical implants like hip replacements and spinal fusion machines are among them. Orthopedic devices help patients live better lives by reducing pain and enhancing their quality of life, in addition to helping them regain function and mobility.

According to the World Health Organization (WHO), the global population aged 60 years and older is expected to reach 2.1 billion by 2050.

Market Dynamics:

Driver:

Growing rate of chronic illnesses

The market is directly impacted by the rise in chronic illnesses like diabetes and obesity that are occurring worldwide. Osteoarthritis is more common in obese people because obesity increases the mechanical load on joints, especially the knees and hips. Diabetes has been linked to complications like Charcot foot, a condition where the foot's bones weaken and necessitate orthopedic device surgery. Additionally, the prevalence of these chronic conditions is rising as a result of changes in lifestyle, and this is driving up demand for orthopedic treatments like spinal devices, joint replacement surgery, and pain management to increase mobility.

Restraint:

High costs of device development

Developing advanced orthopedic devices involves substantial investments in research, clinical trials, and regulatory approvals. This financial burden is amplified by the need for cutting-edge technology and materials to ensure safety and efficacy. Additionally, stringent regulatory standards necessitate extensive testing, further increasing costs. These high development expenses can limit market entry for new companies, reduce innovation, and lead to higher prices for end-users, thereby impacting overall market growth.

Opportunity:

Developments in custom implants and personalized medicine

The market is expanding due to the trend toward personalized medicine. Custom implants that are made to fit each patient's unique anatomy are now possible, due to developments in 3D printing and imaging technologies. Better surgical results, quicker recovery periods, and increased patient satisfaction are all possible with this individualized approach. Additionally, bespoke knee and hip implants that precisely match the bone structure of the patient can lengthen the device's lifespan and lower the risk of implant failure. Opportunities for businesses to create and sell customized orthopedic solutions will increase as these technologies develop further.

Threat:

Strong pricing pressures and market competition

Post-surgical complications pose a significant threat to the orthopedic devices market, impacting patient recovery and increasing healthcare costs. Issues such as infections, implant failures, and adverse reactions can lead to prolonged hospital stays, additional surgeries, and increased morbidity. These complications not only hinder patient outcomes but also affect the reputation and financial performance of orthopedic device manufacturers.

Covid-19 Impact:

The postponement of elective surgeries, such as joint replacements and other non-emergency orthopedic procedures, as healthcare systems concentrated on managing the surge of COVID-19 cases, had a significant impact on the orthopedic devices market during the COVID-19 pandemic. As a result, at the height of the pandemic, there was a notable drop in the market for orthopedic devices. Moreover, production and distribution were made even more difficult by supply chain interruptions, which also had an impact on the availability of components and raw materials.

The joint reconstruction devices segment is expected to be the largest during the forecast period

In the orthopedic devices market, the joint reconstruction devices segment has the largest market share. As osteoarthritis, rheumatoid arthritis, and other joint-related disorders are becoming more common, especially in the aging population, there is a high demand for joint replacement surgeries, such as hip and knee replacements, which is the main cause of this dominance. Additionally, this market has grown even more as a result of technological developments in joint reconstruction, such as the creation of biocompatible and longer-lasting materials, the use of less invasive surgery, and the increasing popularity of customized implants.

The polymers segment is expected to have the highest CAGR during the forecast period

The polymers segment is anticipated to achieve the highest compound annual growth rate in the orthopedic devices market during the forecast period. This growth is driven by the increasing adoption of advanced polymer materials in orthopedic implants and devices due to their superior biocompatibility, flexibility, and durability. Innovations in polymer technology enable the development of lightweight, high-performance devices that enhance patient outcomes. Additionally, the rising demand for minimally invasive surgical procedures and the aging global population further contribute to the segment's rapid expansion.

Region with largest share:

In the orthopedic devices market, North America commands the largest share. The region's high incidence of orthopedic disorders, substantial investment in medical R&D, and sophisticated healthcare infrastructure are the main factors contributing to its dominance. With a large aging population, a strong healthcare system, and a high demand for cutting-edge orthopedic solutions, the U.S. in particular contributes significantly to this share. Moreover, the market leadership of North America is further strengthened by the existence of top orthopedic device manufacturers and robust support from insurance systems.

Region with highest CAGR:

The orthopedic devices market is expanding at the highest CAGR in the Asia-Pacific region. Numerous factors, such as the growing population, the rise in the frequency of orthopedic conditions, and the development of the healthcare system in nations like China and India, are responsible for this quick growth. The rise in demand for orthopedic devices in the area is also attributed to the development of healthcare facilities, the rising cost of medical care, and a greater understanding of orthopedic health. Furthermore, the remarkable growth trajectory of the Asia-Pacific market can also be attributed to the influx of international players.

Key players in the market

Some of the key players in Orthopedic Devices market include Arthrex, B. Braun Melsungen AG, Conmed Corporation, Enovis Corporation, Exactech, Inc., Globus Medical, Inc., Integra LifeSciences Corporation, Johnson & Johnson (DePuy Synthes), Medtronic plc, NuVasive, Orthofix, OrthoPediatrics, Ossur, Paragon 28, Smith & Nephew, Stryker Corporation, Think Surgical and Zimmer Biomet.

Key Developments:

In September 2023, Globus Medical Inc. GMED recently announced that it has successfully closed the previously announced merger with NuVasive. The combined firm will offer one of the most extensive selections of musculoskeletal procedural solutions, enabling technology to influence the care continuum for surgeons and patients.

In September 2023, US-based orthopedics company Enovis has announced plans to acquire surgical implant maker LimaCorporate S.p.A (Lima), to expand its global reach and portfolio of products. Under the terms of the agreement, Enovis will obtain Italy-based Lima in a transaction valued at €800 million ($847 million) made up of a cash payment of €700 million, and €100 million in shares of Enovis common stock, issued within 18 months after closing.

In June 2023, Arterex, a medical device contract manufacturer, has signed an agreement to acquire NextPhase Medical Devices for an undisclosed amount. NextPhase is a class II and III medical device contract manufacturer of complex electromechanical devices, active implantable devices, and single use disposables in North America.

Product Types Covered:

• Joint Reconstruction Devices
• Spine Implants
• Trauma & Orthopedic Trauma
• Orthopedic Instruments
• Bone Cements
• Other Orthopedic Devices

Material Types Covered:

• Metals
• Polymers
• Ceramics
• Composites
• Other Material Types

Distribution Channels Covered:

• Direct Sales
• Distributors
• Retailers
• Online Sales

End Users Covered:

• Hospitals
• Orthopedic Clinics
• Ambulatory Surgical Centers (ASCs)
• Rehabilitation Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances